Envestnet Asset Management Inc Iovance Biotherapeutics, Inc. Transaction History

Envestnet Asset Management Inc

$326 Billion
Q2 2025

A detailed history of Envestnet Asset Management Inc transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 47,466 shares of IOVA stock, worth $106,323. This represents 0.0% of its overall portfolio holdings.

Number of Shares

47,466

Previous 22,383 112.06%

Holding current value

$106,323

Previous $74,000 9.46%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 31, 2025	BUY	$1.66 - $3.61 $41,637 - $90,549	25,083 Added 112.06%	47,466 $81,000
Q1 2025 Apr 29, 2025	SELL	$3.33 - $7.79 $18,474 - $43,218	-5,548 Reduced 19.86%	22,383 $74,000
Q4 2024 Feb 12, 2025	SELL	$7.17 - $12.28 $10,367 - $17,756	-1,446 Reduced 4.92%	27,931 $206,000
Q3 2024 Nov 06, 2024	BUY	$7.28 - $11.9 $26,091 - $42,649	3,584 Added 13.9%	29,377 $275,000
Q2 2024 Aug 08, 2024	SELL	$7.78 - $14.19 $43,373 - $79,109	-5,575 Reduced 17.77%	25,793 $206,000
Q1 2024 May 13, 2024	BUY	$7.59 - $17.47 $52,803 - $121,538	6,957 Added 28.5%	31,368 $464,000
Q4 2023 Feb 13, 2024	SELL	$3.3 - $8.89 $1,211 - $3,262	-367 Reduced 1.48%	24,411 $198,000
Q3 2023 Nov 13, 2023	BUY	$4.44 - $8.79 $25,734 - $50,946	5,796 Added 30.53%	24,778 $112,000
Q2 2023 Aug 04, 2023	SELL	$5.36 - $9.06 $20,223 - $34,183	-3,773 Reduced 16.58%	18,982 $133,000
Q1 2023 May 11, 2023	BUY	$5.53 - $8.22 $125,835 - $187,046	22,755 New	22,755 $139,000
Q2 2022 Aug 03, 2022	SELL	$6.38 - $18.33 $89,428 - $256,931	-14,017 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$12.38 - $19.1 $25,985 - $40,090	2,099 Added 17.61%	14,017 $233,000
Q4 2021 Feb 04, 2022	BUY	$16.55 - $27.63 $1,059 - $1,768	64 Added 0.54%	11,918 $228,000
Q3 2021 Oct 07, 2021	SELL	$20.35 - $26.63 $18,111 - $23,700	-890 Reduced 6.98%	11,854 $292,000
Q2 2021 Aug 04, 2021	SELL	$16.33 - $33.07 $10,712 - $21,693	-656 Reduced 4.9%	12,744 $332,000
Q1 2021 May 04, 2021	BUY	$28.67 - $52.59 $229 - $420	8 Added 0.06%	13,400 $424,000
Q4 2020 Feb 02, 2021	SELL	$28.04 - $50.26 $34,208 - $61,317	-1,220 Reduced 8.35%	13,392 $621,000
Q3 2020 Oct 09, 2020	BUY	$27.75 - $36.3 $44,039 - $57,608	1,587 Added 12.18%	14,612 $481,000
Q2 2020 Jul 08, 2020	BUY	$27.21 - $41.0 $49,440 - $74,497	1,817 Added 16.21%	13,025 $358,000
Q1 2020 Apr 23, 2020	BUY	$19.54 - $38.85 $219,004 - $435,430	11,208 New	11,208 $336,000

Others Institutions Holding IOVA

# of Institutions

292

Shares Held

233M

Call Options Held

1.14M

Put Options Held

1.15M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $353M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account

Envestnet Asset Management Inc Iovance Biotherapeutics, Inc. Transaction History